Literature DB >> 21373209

First Revision of the German S3 Guideline 'Diagnosis, Therapy, and Follow-Up of Breast Cancer'

Achim Wöckel1, Rolf Kreienberg.   

Abstract

The development and implementation of evidence-based, interdisciplinary, consensus-based guidelines is a very important step towards decreasing breast cancer mortality and optimizing the process of early detection, diagnosis, therapy, and follow-up of breast cancer. A revised version of the German S3 guideline was published in February 2008. Different working groups, departments, and organizations participate as coeditors of the new guideline. To fulfill international methodic requirements, a systematic search of the literature with selection of new publications (used as evidence) in the established data bases (Medline, BIOSIS, Previews, CDSR, ACP Journal Club, DARE, CCTR, CINHAL) and the Guidelines International Network (GIN) was performed for the time period of 2003-2006. Varied specialist opinions concerning diagnosis, therapy, and follow-up of breast cancer were considered in formal consensus processes. In different steps, Nominal Group Process techniques, the Delphi technique, and formal consensus processes were used. Besides differently weighted, study-based recommendations, statements resulting from structured consensus finding by the interdisciplinary group - in terms of good clinical practice - were postulated.

Entities:  

Year:  2008        PMID: 21373209      PMCID: PMC2931080          DOI: 10.1159/000127509

Source DB:  PubMed          Journal:  Breast Care (Basel)        ISSN: 1661-3791            Impact factor:   2.860


  1 in total

1.  [Developing a methodology for drawing up guidelines on best medical practices. (Recommendation (2001)13 and explanatory memorandum)].

Authors: 
Journal:  Z Arztl Fortbild Qualitatssich       Date:  2002-12
  1 in total
  11 in total

1.  Initial results of the FUSION-X-US prototype combining 3D automated breast ultrasound and digital breast tomosynthesis.

Authors:  Benedikt Schaefgen; Joerg Heil; Richard G Barr; Marcus Radicke; Aba Harcos; Christina Gomez; Anne Stieber; André Hennigs; Alexandra von Au; Julia Spratte; Geraldine Rauch; Joachim Rom; Florian Schütz; Christof Sohn; Michael Golatta
Journal:  Eur Radiol       Date:  2018-01-04       Impact factor: 5.315

2.  Results of the First Austrian Multidisciplinary Expert Panel on Controversies in Local Treatment of Breast Cancer.

Authors:  Michael Knauer; Michael Gnant; Florian Fitzal
Journal:  Breast Care (Basel)       Date:  2012-02-20       Impact factor: 2.860

Review 3.  Cancer Treatment-Induced Bone Loss in women with breast cancer.

Authors:  Peyman Hadji
Journal:  Bonekey Rep       Date:  2015-05-20

4.  Quality assessment of HER2 testing by monitoring of positivity rates.

Authors:  Harald Choritz; Guntram Büsche; Hans Kreipe
Journal:  Virchows Arch       Date:  2011-08-02       Impact factor: 4.064

5.  Can ki-67 play a role in prediction of breast cancer patients' response to neoadjuvant chemotherapy?

Authors:  Juhasz-Böss Ingolf; Mavrova Russalina; Moga Simona; Radosa Julia; Schmidt Gilda; Rainer M Bohle; Hasenfus Andrea; Solomayer Erich; Herr Daniel
Journal:  Biomed Res Int       Date:  2014-03-25       Impact factor: 3.411

6.  Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients.

Authors:  Patricia R Blank; Martin Filipits; Peter Dubsky; Florian Gutzwiller; Michael P Lux; Jan C Brase; Karsten E Weber; Margaretha Rudas; Richard Greil; Sibylle Loibl; Thomas D Szucs; Ralf Kronenwett; Matthias Schwenkglenks; Michael Gnant
Journal:  Pharmacoeconomics       Date:  2015-02       Impact factor: 4.981

Review 7.  From High-Throughput Microarray-Based Screening to Clinical Application: The Development of a Second Generation Multigene Test for Breast Cancer Prognosis.

Authors:  Jan C Brase; Ralf Kronenwett; Christoph Petry; Carsten Denkert; Marcus Schmidt
Journal:  Microarrays (Basel)       Date:  2013-08-29

8.  Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques.

Authors:  Joerg Heil; Sherko Kümmel; Benedikt Schaefgen; Stefan Paepke; Christoph Thomssen; Geraldine Rauch; Beyhan Ataseven; Regina Große; Volker Dreesmann; Thorsten Kühn; Sibylle Loibl; Jens-Uwe Blohmer; Gunter von Minckwitz
Journal:  Br J Cancer       Date:  2015-11-10       Impact factor: 7.640

9.  RESPONDER - diagnosis of pathological complete response by vacuum-assisted biopsy after neoadjuvant chemotherapy in breast Cancer - a multicenter, confirmative, one-armed, intra-individually-controlled, open, diagnostic trial.

Authors:  Joerg Heil; Peter Sinn; Hannah Richter; André Pfob; Benedikt Schaefgen; André Hennigs; Fabian Riedel; Bettina Thomas; Marc Thill; Markus Hahn; Jens-Uwe Blohmer; Sherko Kuemmel; Maria Margarete Karsten; Mattea Reinisch; John Hackmann; Toralf Reimer; Geraldine Rauch; Michael Golatta
Journal:  BMC Cancer       Date:  2018-08-25       Impact factor: 4.430

10.  Impact of Nuclear Oestrogen Receptor Beta Expression in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy.

Authors:  Florian Heitz; Sherko Kümmel; Bianca Lederer; Christine Solbach; Knut Engels; Beyhan Ataseven; Bruno Sinn; Jens Uwe Blohmer; Carsten Denkert; Jana Barinoff; Annette Fisseler-Eckhoff; Sibylle Loibl
Journal:  Geburtshilfe Frauenheilkd       Date:  2019-10-22       Impact factor: 2.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.